Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
about
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the futureManagement of the polyallergic patient with allergy immunotherapy: a practice-based approachLatest developments in allergic rhinitis in Allergy for clinicians and researchers.Allergen extracts for immunotherapy: to mix or not to mix?Allergen immunotherapy for birch pollen-allergic patients: recent advances.Proteomics for Allergy: from Proteins to the Patients.IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment.Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.Tackling Bet v 1 and associated food allergies with a single hybrid protein.Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.Next generation immunotherapy for tree pollen allergies.Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.
P2860
Q26768511-FEBA2426-4B50-4F4A-8D35-C41E92047082Q26772200-E92FE6B2-A3CC-4BDA-BDA9-1872425F0538Q38600884-A141DB9D-C735-4965-A995-1B0A760BEBC7Q38664847-5F49E676-8A87-477C-AE7B-8A828B5D30AEQ38824177-21CB32F7-D90A-48A6-B630-F7A7165CF832Q38930142-F093987B-95FA-4D67-9010-0957CB034BF6Q38973411-13861775-1D9F-4660-8ACF-A33A52494AB9Q39384289-8747EBA0-3E33-420C-AA10-3BBCA834FF9AQ40087434-A8B620E5-7385-4596-B86E-4A056414CFF9Q41769755-BFF27D50-0127-4321-99D8-0B2D2709CD23Q47095653-27851A23-0517-4906-B696-86755DE1DF3BQ47713994-DF42AD91-6730-4E42-B8B1-69D58895E383Q47884083-721A8A6B-8373-4ABD-9931-DF1DE4210EDFQ48240468-5366470B-3E24-4502-BD08-A1AFA655640BQ55436442-2C9067F4-64F5-4E0B-98B4-9B3C29FB5D2A
P2860
Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Development and evaluation of ...... birch pollen-allergic patients
@ast
Development and evaluation of ...... birch pollen-allergic patients
@en
Development and evaluation of ...... birch pollen-allergic patients
@nl
type
label
Development and evaluation of ...... birch pollen-allergic patients
@ast
Development and evaluation of ...... birch pollen-allergic patients
@en
Development and evaluation of ...... birch pollen-allergic patients
@nl
prefLabel
Development and evaluation of ...... birch pollen-allergic patients
@ast
Development and evaluation of ...... birch pollen-allergic patients
@en
Development and evaluation of ...... birch pollen-allergic patients
@nl
P2093
P2860
P356
P1433
P1476
Development and evaluation of ...... birch pollen-allergic patients
@en
P2093
K Abiteboul
L Mascarell
M Arvidsson
M Le Mignon
M Pallardy
O de Beaumont
P2860
P304
P356
10.1111/ALL.12622
P577
2015-07-01T00:00:00Z